miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β

dc.contributor.authorBu, Pengcheng
dc.contributor.authorWang, Lihua
dc.contributor.authorChen, Kai-Yuan
dc.contributor.authorRakhilin, Nikolai
dc.contributor.authorSun, Jian
dc.contributor.authorClosa, Adrià
dc.contributor.authorTung, Kuei-Ling
dc.contributor.authorKing, Sarah
dc.contributor.authorKristine Varanko, Anastasia
dc.contributor.authorXu, Yitian
dc.contributor.authorHuan Chen, Joyce
dc.contributor.authorZessin, Amelia S.
dc.contributor.authorShealy, James
dc.contributor.authorCummings, Bethany
dc.contributor.authorHsu, David
dc.contributor.authorLipkin, Steven M.
dc.contributor.authorMoreno Aguado, Víctor
dc.contributor.authorGümüş, Zeynep H.
dc.contributor.authorShen, Xiling
dc.date.accessioned2018-10-24T11:39:18Z
dc.date.available2018-10-24T11:39:18Z
dc.date.issued2015-04-15
dc.date.updated2018-10-24T11:39:23Z
dc.description.abstractAs patient survival drops precipitously from early-stage cancers to late-stage and metastatic cancers, microRNAs that promote relapse and metastasis can serve as prognostic and predictive markers as well as therapeutic targets for chemoprevention. Here we show that miR-1269a promotes colorectal cancer (CRC) metastasis and forms a positive feedback loop with TGF-β signalling. miR-1269a is upregulated in late-stage CRCs, and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis. Consistent with clinical observations, miR-1269a significantly increases the ability of CRC cells to invade and metastasize in vivo. TGF-β activates miR-1269 via Sox4, while miR-1269a enhances TGF-β signalling by targeting Smad7 and HOXD10, hence forming a positive feedback loop. Our findings suggest that miR-1269a is a potential marker to inform adjuvant chemotherapy decisions for CRC patients and a potential therapeutic target to deter metastasis.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec660205
dc.identifier.issn2041-1723
dc.identifier.pmid25872451
dc.identifier.urihttps://hdl.handle.net/2445/125584
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/ncomms7879
dc.relation.ispartofNature Communications, 2015, vol. 15, num. 6, p. 6879
dc.relation.urihttps://doi.org/10.1038/ncomms7879
dc.rightscc-by (c) Bu, Pengcheng et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer
dc.subject.classificationQuimioteràpia del càncer
dc.subject.classificationMetàstasi
dc.subject.otherCancer
dc.subject.otherCancer chemotherapy
dc.subject.otherMetastasis
dc.titlemiR-1269 promotes metastasis and forms a positive feedback loop with TGF-β
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
660205.pdf
Mida:
3.08 MB
Format:
Adobe Portable Document Format